首页 | 本学科首页   官方微博 | 高级检索  
检索        


Clinical Outcomes in Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients: A Multicenter Registry-based Cohort Study
Institution:1. Departments of Premier Preventive Medicine, Graduate School of Medicine, Osaka City University, Osaka, Japan;3. Department of Hepatology, Graduate School of Medicine, Osaka City University, Osaka, Japan;4. Division of Gastroenterology and Hepatology, Yokohama City University Graduate School of Medicine, Yokohama, Japan;5. Department of Gastroenterology, Ogaki Municipal Hospital, Ogaki, Japan;7. Department of Laboratory Medicine, Saga University Hospital, Saga, Japan;12. Department of Gastroenterology, JA Hiroshima Kouseiren General Hospital, Hatsukaichi, Hiroshima, Japan;8. Department of General Internal Medicine 2, Kawasaki Medical Center, Kawasaki Medical School, Okayama, Japan;9. Department of Gastroenterology and Hepatology, Kochi Medical School, Kochi, Japan;71. Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume, Japan;123. Liver Disease Care Unit, Division of Metabolism and Biosystemic Science, Gastroenterology, and Hematology/Oncology, Asahikawa Medical University, Asahikawa, Japan;84. Department of Medicine, Asahikawa Medical University, Asahikawa, Japan;95. Division of Hepatology, Shimane University Hospital, Shimane, Japan;77. Division of Innovative Medicine for Hepatobiliary & Pancreatology, Faculty of Medicine, Kagawa University, Kagawa, Japan;1212. Department of Cardiovascular Medicine and Hypertension, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan;88. Department of Advanced Metabolic Hepatology, Osaka University, Graduate School of Medicine, Osaka, Japan;99. Department of Pathology and Microbiology, Faculty of Medicine, Saga University, Saga, Japan;771. Hepatology Center, Saiseikai Suita Hospital, Suita, Osaka, Japan
Abstract:
><ol class=
  • Download : Download high-res image (312KB)
  • Download : Download full-size image
  • Keywords:Asian  Cirrhosis  Fibrosis  Liver-related Mortality  BMI"}  {"#name":"keyword"  "$":{"id":"kwrd0035"}  "$$":[{"#name":"text"  "_":"body mass index  CI"}  {"#name":"keyword"  "$":{"id":"kwrd0045"}  "$$":[{"#name":"text"  "_":"confidence interval  CVD"}  {"#name":"keyword"  "$":{"id":"kwrd0055"}  "$$":[{"#name":"text"  "_":"cardiovascular disease  F"}  {"#name":"keyword"  "$":{"id":"kwrd0065"}  "$$":[{"#name":"text"  "_":"fibrosis stage  FLIP"}  {"#name":"keyword"  "$":{"id":"kwrd0075"}  "$$":[{"#name":"text"  "_":"fatty liver inhibition of progression  HCC"}  {"#name":"keyword"  "$":{"id":"kwrd0085"}  "$$":[{"#name":"text"  "_":"hepatocellular carcinoma  HCV"}  {"#name":"keyword"  "$":{"id":"kwrd0095"}  "$$":[{"#name":"text"  "_":"hepatitis C virus  HR"}  {"#name":"keyword"  "$":{"id":"kwrd0105"}  "$$":[{"#name":"text"  "_":"hazard ratio  NAFLD"}  {"#name":"keyword"  "$":{"id":"kwrd0115"}  "$$":[{"#name":"text"  "_":"nonalcoholic fatty liver disease  NAS"}  {"#name":"keyword"  "$":{"id":"kwrd0125"}  "$$":[{"#name":"text"  "_":"NAFLD activity score  NASH"}  {"#name":"keyword"  "$":{"id":"kwrd0135"}  "$$":[{"#name":"text"  "_":"nonalcoholic steatohepatitis
    本文献已被 ScienceDirect 等数据库收录!
    设为首页 | 免责声明 | 关于勤云 | 加入收藏

    Copyright©北京勤云科技发展有限公司  京ICP备09084417号